Author's posts
Cancer care costs everyone too much. What can we do about it?
Today’s fee-for-service oncology business model misaligns incentives by rewarding practices for keeping margins and service volumes high — even when it’s wasteful — rather than for optimizing patient outcomes. While discussions of drug pric…
